[go: up one dir, main page]

ZA977427B - 2,4-disubstituted pyrimidine derivative, process for preparing the same, and a pharmaceutical composition containing the same. - Google Patents

2,4-disubstituted pyrimidine derivative, process for preparing the same, and a pharmaceutical composition containing the same.

Info

Publication number
ZA977427B
ZA977427B ZA9707427A ZA977427A ZA977427B ZA 977427 B ZA977427 B ZA 977427B ZA 9707427 A ZA9707427 A ZA 9707427A ZA 977427 A ZA977427 A ZA 977427A ZA 977427 B ZA977427 B ZA 977427B
Authority
ZA
South Africa
Prior art keywords
same
preparing
pharmaceutical composition
composition containing
pyrimidine derivative
Prior art date
Application number
ZA9707427A
Other languages
English (en)
Inventor
Teruya Murata
Katsunori Kondo
Kiyoshi Furukawa
Makoto Oka
Original Assignee
Dainippon Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co
Publication of ZA977427B publication Critical patent/ZA977427B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9707427A 1996-09-04 1997-08-19 2,4-disubstituted pyrimidine derivative, process for preparing the same, and a pharmaceutical composition containing the same. ZA977427B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25542096 1996-09-04

Publications (1)

Publication Number Publication Date
ZA977427B true ZA977427B (en) 1998-03-02

Family

ID=17278521

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9707427A ZA977427B (en) 1996-09-04 1997-08-19 2,4-disubstituted pyrimidine derivative, process for preparing the same, and a pharmaceutical composition containing the same.

Country Status (5)

Country Link
AR (1) AR009523A1 (id)
AU (1) AU4134297A (id)
ID (1) ID17076A (id)
WO (1) WO1998009960A1 (id)
ZA (1) ZA977427B (id)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432947B1 (en) 1997-02-19 2002-08-13 Berlex Laboratories, Inc. N-heterocyclic derivatives as NOS inhibitors
JP2002241369A (ja) * 1998-05-18 2002-08-28 Dainippon Pharmaceut Co Ltd ４−ピリミジニルアミノアセトアミド誘導体及びそれを含有する医薬組成物
WO2000042025A1 (fr) * 1999-01-14 2000-07-20 Meiji Seika Kaisha, Ltd. Inhibiteurs de poly(adp-ribose) polymerase consistant en des derives de pyrimidine
CA2390259A1 (en) 1999-11-17 2001-05-25 Mari Itoh ¬5-chloro-6-phenyl-2-(4-trifluoromethylphenyl)-4-pyrimidinylamino|acetamide derivatives, process for preparing the same, medicinal compositions containing the same, and intermediate of these compounds
US6525051B2 (en) 2000-03-27 2003-02-25 Schering Aktiengesellschaft N-heterocyclic derivatives as NOS inhibitors
ATE466581T1 (de) * 2001-12-07 2010-05-15 Vertex Pharma Verbindungen auf pyrimidin-basis als gsk-3-hemmer
US6982259B2 (en) 2002-04-30 2006-01-03 Schering Aktiengesellschaft N-heterocyclic derivatives as NOS inhibitors
US7816353B2 (en) * 2003-10-24 2010-10-19 Exelixis, Inc. P70S6 kinase modulators and method of use
EP1939181A1 (en) * 2006-12-27 2008-07-02 sanofi-aventis Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase
WO2008116139A2 (en) * 2007-03-22 2008-09-25 Vertex Pharmaceuticals Incorporated N-heterocyclic compounds useful as inhibitors of janus kinases
GB0808664D0 (en) * 2008-05-13 2008-06-18 Syngenta Ltd Chemical compounds
US8691866B2 (en) 2008-12-10 2014-04-08 The General Hospital Corporation HIF inhibitors and use thereof
JP2012529535A (ja) 2009-06-12 2012-11-22 ブリストル−マイヤーズ スクイブ カンパニー キナーゼモジュレーターとして有用なニコチンアミド化合物
MA54300A (fr) * 2018-11-30 2021-10-13 Celularity Inc Composés aromatiques pour l'utilisation dans l'activation de cellules souches et progénitrices hématopoïétiques
JP7471407B2 (ja) * 2020-05-19 2024-04-19 ユニマテック株式会社 含フッ素ピリミジン化合物および含フッ素ピリミジノン化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0710874A (ja) * 1993-04-28 1995-01-13 Dainippon Pharmaceut Co Ltd ３−（１，２，４−オキサジアゾリル）−５，６，７，８−テトラヒドロ−１，６−ナフチリジン誘導体
JPH07165721A (ja) * 1993-12-15 1995-06-27 Sumitomo Chem Co Ltd 放射性イソキノリンカルボキサミド誘導体

Also Published As

Publication number Publication date
AR009523A1 (es) 2000-04-26
AU4134297A (en) 1998-03-26
ID17076A (id) 1997-12-04
WO1998009960A1 (fr) 1998-03-12

Similar Documents

Publication Publication Date Title
IL135920A0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
PL332040A1 (en) Substitution 6,5-heterobicyclic derivatives
PL331988A1 (en) Substitution 6,6-heterobicyclic derivatives
PH30894A (en) 1,5-Benzodiazepine derivative.
IL118426A0 (en) Pharmaceutical composition containing 1,3-bis-triazolyl-2- propanol derivative
ZA977427B (en) 2,4-disubstituted pyrimidine derivative, process for preparing the same, and a pharmaceutical composition containing the same.
EP1023250A4 (en) METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE
HUP9701660A3 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]pentadekanon derivatives, process for producing them, and pharmaceutical compositions containing them
HUP9602868A3 (en) 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP9900621A3 (en) 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives, process to prepare them and pharmaceuticals contg. the said compds.
IL134572A0 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6- methano-3-benzazocine-10-oles, methods for the production and use thereof as medicaments
IL126989A0 (en) Process for making 4,6-dihydroxypyrimidine
HUP0000090A3 (en) 1,4-disubstituted piperazines, pharmaceutical compositions containing them, process for producing them and their use
HU9602763D0 (en) Novel isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
AU3255997A (en) Process for preparing 1,3-alkanediols
HUP0004457A3 (en) Angiogenesis inhibiting thiadiazolyl-pyridazine derivatives, process for producing them and pharmaceutical compositions containing the same
ZA977870B (en) Crystalline pharmaceutical product.
AU8312191A (en) 1,4-disubstituted piperazines
HU9900263D0 (en) 11-acetyl-12,13-dioxabicyclo[8.2.1.]tridecenon derivatives, process for producing them and pharmaceutical compositions containing them
HUP9701922A3 (en) Substituted 7,12-dioxabenz[a]antracene derivatives, process for preparing the same and pharmaceuticals containing them
HUP0004357A3 (en) Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives, process for producing them and pharmaceutical compositions containing the same
HRP970162A2 (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
EP0678293A3 (de) Pyridoxinester enthaltendes Präparat, Verfahren zu dessen Herstellung und dessen Verwendung.
AU6086998A (en) Process for preparing 1,4-disubstituted piperidine compounds
AU3026697A (en) Process for preparing 4,6-diamino-resorcinol-dihydrochloride